Pompe Disease

Drug Name: Pombiliti Active Ingredient:  cipaglucosidase alfa-atga Indications: To treat late-onset Pompe disease Approval Date: 9/28/2023 Company: Amicus Therapeutics, Inc. More:  https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761204s000lbl.pdf